JP2025508343A5 - - Google Patents
Info
- Publication number
- JP2025508343A5 JP2025508343A5 JP2024545274A JP2024545274A JP2025508343A5 JP 2025508343 A5 JP2025508343 A5 JP 2025508343A5 JP 2024545274 A JP2024545274 A JP 2024545274A JP 2024545274 A JP2024545274 A JP 2024545274A JP 2025508343 A5 JP2025508343 A5 JP 2025508343A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- amino acid
- acid sequence
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210111504 | 2022-01-29 | ||
| CN202210111504.5 | 2022-01-29 | ||
| CN202210985594 | 2022-08-17 | ||
| CN202210985594.0 | 2022-08-17 | ||
| PCT/CN2023/073614 WO2023143537A1 (zh) | 2022-01-29 | 2023-01-28 | Gprc5d抗体及其应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508343A JP2025508343A (ja) | 2025-03-26 |
| JP2025508343A5 true JP2025508343A5 (enExample) | 2026-02-05 |
Family
ID=87470681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024545274A Pending JP2025508343A (ja) | 2022-01-29 | 2023-01-28 | Ｇｐｒｃ５ｄ抗体及びその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250121064A1 (enExample) |
| EP (1) | EP4471065A4 (enExample) |
| JP (1) | JP2025508343A (enExample) |
| KR (1) | KR20240137090A (enExample) |
| CN (1) | CN118613507A (enExample) |
| WO (1) | WO2023143537A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025056013A1 (zh) * | 2023-09-13 | 2025-03-20 | 江苏恒瑞医药股份有限公司 | 一种包含特异性结合gprc5d和cd3的双特异性抗体的药物组合物 |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025103456A1 (en) * | 2023-11-15 | 2025-05-22 | Nanjing Legend Biotech Co., Ltd. | Gprc5d-binding moieties, chimeric antigen receptors and uses thereof |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| US12545726B1 (en) | 2025-07-22 | 2026-02-10 | Integral Molecular, Inc. | Compositions and methods related to GPRC5D binding agents and variants thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| CA2903234C (en) | 2013-03-13 | 2018-08-28 | Mallinckrodt Llc | Liposome oxaliplatin compositions for cancer therapy |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| CN118271463A (zh) | 2014-12-05 | 2024-07-02 | 纪念斯隆-凯特琳癌症中心 | 靶向g-蛋白偶联受体的嵌合抗原受体及其用途 |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| SG11201907321TA (en) * | 2017-02-07 | 2019-09-27 | Daiichi Sankyo Co Ltd | Anti-gprc5d antibody and molecule comprising the antibody |
| TWI829667B (zh) * | 2018-02-09 | 2024-01-21 | 瑞士商赫孚孟拉羅股份公司 | 結合gprc5d之抗體 |
| CN114174338A (zh) * | 2019-07-31 | 2022-03-11 | 豪夫迈·罗氏有限公司 | 与gprc5d结合的抗体 |
-
2023
- 2023-01-28 EP EP23746414.4A patent/EP4471065A4/en active Pending
- 2023-01-28 CN CN202380019068.1A patent/CN118613507A/zh active Pending
- 2023-01-28 KR KR1020247028927A patent/KR20240137090A/ko active Pending
- 2023-01-28 US US18/834,017 patent/US20250121064A1/en active Pending
- 2023-01-28 WO PCT/CN2023/073614 patent/WO2023143537A1/zh not_active Ceased
- 2023-01-28 JP JP2024545274A patent/JP2025508343A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508343A5 (enExample) | ||
| KR102944460B1 (ko) | Cldn18.2 및 cd3에 대한 항체 작제물 | |
| US20260116974A1 (en) | Novel anti-cd3epsilon antibodies | |
| CN114127111B (zh) | 与nkp30结合的抗体分子及其用途 | |
| JP2026009903A (ja) | 新規な抗ｔｃｒデルタ可変１抗体 | |
| US20240052052A1 (en) | Novel anti-cd24 antibodies | |
| JP2022542559A5 (enExample) | ||
| CA3201518A1 (en) | Bi-functional molecules | |
| CN116917316A (zh) | 与NKp30结合的抗体分子及其用途 | |
| WO2024131962A1 (zh) | 新型抗gprc5d抗体 | |
| WO2020192709A1 (en) | Novel bispecific polypeptide complexes | |
| JP2023547662A (ja) | Ｃｌｄｎ６及びｃｄ３に選択的に結合するポリペプチド構築物 | |
| TW202346368A (zh) | 具有增加的選擇性的多鏈多靶向性雙特異性抗原結合分子 | |
| US12486325B2 (en) | Anti-CD3epsilon antibodies | |
| KR20240040093A (ko) | scFv 등의 링커에 결합하는 항체 | |
| US20220306741A1 (en) | Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity | |
| TW202317618A (zh) | 新型抗ｃｄ２７６抗體及其用途 | |
| EA051514B1 (ru) | Полипептидные конструкции, селективно связывающиеся с cldn6 и cd3 | |
| EA052500B1 (ru) | Новые антитела против cd24 | |
| EA051087B1 (ru) | Нацеливающиеся на несколько мишеней биспецифические антигенсвязывающие молекулы повышенной селективности |